Literature DB >> 22669453

Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.

Johannes Betge1, Peter Kornprat, Marion J Pollheimer, Richard A Lindtner, Andrea Schlemmer, Peter Rehak, Michael Vieth, Cord Langner.   

Abstract

BACKGROUND: In colorectal cancer, the morphology of the invasive tumor margin may reflect aggressiveness of tumor growth, thus providing important prognostic information. The tumor growth pattern according to Jass and the extent of tumor budding were analyzed in patients with American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) stage II disease.
METHODS: Tumors of 120 randomly selected patients with AJCC/UICC stage II disease were retrospectively reviewed for tumor growth pattern (expanding vs. infiltrating) and the extent of tumor budding, with high-grade budding reflecting presence of 10 or more budding foci scattered at the invasive tumor margin. Progression-free and cancer-specific survivals were determined by the Kaplan-Meier method. For multivariable analysis, Cox's proportional hazards regression models were performed.
RESULTS: The infiltrating growth pattern was significantly associated with histological subtype and lymphovascular invasion, while high-grade budding was significantly associated with tumor grade and lymphovascular invasion. High-grade budding, but not the infiltrating growth pattern, was significantly associated with outcome in univariable analysis. Cox's proportional hazards regression models proved tumor budding to be an independent predictor of disease progression (hazard ratio 3.91, 95 % confidence interval 1.3-11.77; P = 0.02) and cancer-related death (hazard ratio 5.90, 95 % confidence interval 1.62-21.51; P = 0.007). The combination of infiltrating growth pattern and high-grade budding did not have a stronger prognostic significance than tumor budding alone.
CONCLUSIONS: Tumor budding independently predicted patient outcome in patients with AJCC/UICC stage II colorectal cancer and may therefore be used for accurate prognostication, patient counseling, and design of clinical trials by using integrated multimodal therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22669453     DOI: 10.1245/s10434-012-2426-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  38 in total

Review 1.  Tumour budding in colorectal cancer: what do we know and what can we do?

Authors:  Linde De Smedt; Sofie Palmans; Xavier Sagaert
Journal:  Virchows Arch       Date:  2015-11-27       Impact factor: 4.064

2.  Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer

Authors:  Richard Garfinkle; Lawrence Lee; Marylise Boutros; Marie-Josee Cardin; Alan Spatz; Nancy Morin
Journal:  Can J Surg       Date:  2019-10-01       Impact factor: 2.089

Review 3.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.

Authors:  F Petrelli; E Pezzica; M Cabiddu; A Coinu; K Borgonovo; M Ghilardi; V Lonati; D Corti; S Barni
Journal:  J Gastrointest Cancer       Date:  2015-09

4.  Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence.

Authors:  Seijong Kim; Jung Wook Huh; Woo Yong Lee; Seong Hyeon Yun; Hee Cheol Kim; Yong Beom Cho; Yoon Ah Park; Jung Kyong Shin
Journal:  Int J Colorectal Dis       Date:  2020-02-28       Impact factor: 2.571

Review 5.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

6.  Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.

Authors:  Masamichi Hayashi; Rafael Guerrero-Preston; Jun Okamura; Christina Michailidi; Zubair Kahn; Xiufeng Li; Julie Ahn; Marla Goldsmith; Wayne Koch
Journal:  Ann Surg Oncol       Date:  2014-03-27       Impact factor: 5.344

Review 7.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

8.  Tumor size, tumor location, and antitumor inflammatory response are associated with lymph node size in colorectal cancer patients.

Authors:  Ortrun Rössler; Johannes Betge; Lars Harbaum; Karl Mrak; Jörg Tschmelitsch; Cord Langner
Journal:  Mod Pathol       Date:  2017-02-24       Impact factor: 7.842

9.  Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis.

Authors:  Reetesh K Pai; Yu-Wei Cheng; Maureen A Jakubowski; Bonnie L Shadrach; Thomas P Plesec; Rish K Pai
Journal:  Mod Pathol       Date:  2016-10-07       Impact factor: 7.842

Review 10.  Digestive cancer surgery in the era of sentinel node and epithelial-mesenchymal transition.

Authors:  Nadia Peparini
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.